Details

Autor(en) / Beteiligte

• Loibl, S.
• André, F.
• Bachelot, T.
• Barrios, C.H.
• Bergh, J.
• Burstein, H.J.
• Cardoso, M.J.
• Carey, L.A.
• Dawood, S.
• Del Mastro, L.
• Denkert, C.
• Fallenberg, E.M.
• Francis, P.A.
• Gamal-Eldin, H.
• Gelmon, K.
• Geyer, C.E.
• Gnant, M.
• Guarneri, V.
• Gupta, S.
• Kim, S.B.
• Krug, D.
• Martin, M.
• Meattini, I.
• Morrow, M.
• Janni, W.
• Paluch-Shimon, S.
• Partridge, A.
• Poortmans, P.
• Pusztai, L.
• Regan, M.M.
• Sparano, J.
• Spanic, T.
• Swain, S.
• Tjulandin, S.
• Toi, M.
• Trapani, D.
• Tutt, A.
• Xu, B.
• Curigliano, G.
• Harbeck, N.

Titel

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ist Teil von

• Annals of oncology, 2024-02, Vol.35 (2), p.159-182

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2024

Quelle

MEDLINE

Beschreibungen/Notizen

• •This ESMO Clinical Practice Guideline provides key recommendations and algorithms for the management of patients with EBC.•It covers diagnosis, staging, risk assessment, treatment, follow-up, specific situations and the patient perspective.•The author group is multidisciplinary, with experts representing a range of institutions worldwide.•Recommendations, including ESMO-MCBS and ESCAT scores where applicable, are based on available evidence and expert opinion.•Patient communication and shared decision making are covered with respect to diagnostic procedures and treatment options.